138 related articles for article (PubMed ID: 9593221)
21. Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
Morii M; Takeguchi N
J Biol Chem; 1993 Oct; 268(29):21553-9. PubMed ID: 8408006
[TBL] [Abstract][Full Text] [Related]
22. Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry.
Shimatani T; Inoue M; Kuroiwa T; Xu J; Tazuma S; Horikawa Y; Nakamura M
Dig Dis Sci; 2005 Jul; 50(7):1202-6. PubMed ID: 16047460
[TBL] [Abstract][Full Text] [Related]
23. Restoration of acid secretion following treatment with proton pump inhibitors.
Shin JM; Sachs G
Gastroenterology; 2002 Nov; 123(5):1588-97. PubMed ID: 12404233
[TBL] [Abstract][Full Text] [Related]
24. Dissociation of bile flow and biliary lipid secretion from biliary lysosomal enzyme output in experimental cholestasis.
Lopez del Pino VH; LaRusso NF
J Lipid Res; 1981 Feb; 22(2):229-35. PubMed ID: 6787157
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of glandular gastric changes in rats given a proton pump inhibitor for 3 months with emphasis on sampling scheme selection.
White SL; Smith WC; Fisher LF; Gatlin CL; Hanasono GK; Jordan WH
Toxicol Pathol; 1998; 26(3):403-10. PubMed ID: 9608647
[TBL] [Abstract][Full Text] [Related]
26. The effects of rabeprazole on parietal cells and enterochromaffin-like cells in rats: a comparison with omeprazole.
Tari A; Kawano M; Kodama K; Yonei Y; Okahara S; Haruma K; Sumii K; Kajiyama G
J Gastroenterol; 2002; 37(3):177-85. PubMed ID: 11931530
[TBL] [Abstract][Full Text] [Related]
27. New-generation proton pump inhibitors: overcoming the limitations of early-generation agents.
Robinson M
Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S43-7. PubMed ID: 11430508
[TBL] [Abstract][Full Text] [Related]
28. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
Horn J
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
[TBL] [Abstract][Full Text] [Related]
29. Perhexilene: effects on hepatic lysosomal function in rats.
Sewell RB; Horowitz JD; Grinpukel SA; Martin G
Clin Exp Pharmacol Physiol; 1989 Jan; 16(1):25-32. PubMed ID: 2706806
[TBL] [Abstract][Full Text] [Related]
30. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
Fujisaki H; Oketani K; Shibata H; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Takeguchi N
Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
[TBL] [Abstract][Full Text] [Related]
31. Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells.
Itagaki F; Homma M; Takara K; Ohnishi N; Yokoyama T; Sakaeda T; Yagami T; Kobayashi H; Okamura N; Kohda Y
Biol Pharm Bull; 2004 Oct; 27(10):1694-6. PubMed ID: 15467223
[TBL] [Abstract][Full Text] [Related]
32. Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: possible involvement of nitric oxide.
Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
Drugs Exp Clin Res; 2000; 26(2):41-5. PubMed ID: 10894554
[TBL] [Abstract][Full Text] [Related]
33. Effect of benz(a)pyrene and constant light exposure on rat liver lysosomes and biliary excretion of lysosomal enzymes.
Pupyshev AB; Gutina EM; Fedina RG; Michurina SV; Shurlygina AV; Verbitskaya LV
Bull Exp Biol Med; 2005 Jan; 139(1):34-7. PubMed ID: 16142270
[TBL] [Abstract][Full Text] [Related]
34. Rabeprazole: an update of its use in acid-related disorders.
Carswell CI; Goa KL
Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
[TBL] [Abstract][Full Text] [Related]
35. Impaired biliary excretion of copper and lysosomal enzymes in Long-Evans cinnamon.
Abe S; Yamazaki K; Takikawa S; Suzuki K
Tohoku J Exp Med; 1994 Apr; 172(4):355-67. PubMed ID: 7940525
[TBL] [Abstract][Full Text] [Related]
36. Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation.
Homma M; Itagaki F; Yuzawa K; Fukao K; Kohda Y
Transplantation; 2002 Jan; 73(2):303-4. PubMed ID: 11821750
[No Abstract] [Full Text] [Related]
37. Biliary excretion of lysosomal enzymes, iron, and oxidized protein in Fischer-344 and Sprague-Dawley rats and the effects of diquat and acetaminophen.
Gupta S; Rogers LK; Smith CV
Toxicol Appl Pharmacol; 1994 Mar; 125(1):42-50. PubMed ID: 8128494
[TBL] [Abstract][Full Text] [Related]
38. [Recent topics on important drugs for H. pylori eradication: Rabeprazole].
Sugimoto M; Furuta T; Nakmura A; Shirai N
Nihon Rinsho; 2005 Nov; 63 Suppl 11():350-3. PubMed ID: 16363558
[No Abstract] [Full Text] [Related]
39. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.
Shimatani T; Inoue M; Kuroiwa T; Xu J; Mieno H; Nakamura M; Tazuma S
Clin Pharmacol Ther; 2006 Jan; 79(1):144-52. PubMed ID: 16413249
[TBL] [Abstract][Full Text] [Related]
40. Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells.
Yokota T; Matsui H; Matsuura B; Maeyama K; Onji M
Eur J Pharmacol; 2003 Nov; 481(2-3):233-40. PubMed ID: 14642791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
